https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2004-01-01 / Cytotherapy 2004;6(2):154-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2004-01-01 / Cytotherapy 2004;6(2):154-632004-01-01 00:00:002019-02-15 08:50:27The immune response to breast cancer, and the case for DC immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2003 Dec;17(4):365-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2003 Dec;17(4):365-82003-12-01 00:00:002019-02-15 08:37:48[Antiviral effect of human CTLs activated by HBsAg stimulated dendritic cells in vitro]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Hum. Cell 2003 Dec;16(4):175-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Hum. Cell 2003 Dec;16(4):175-822003-12-01 00:00:002019-02-15 08:46:08Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Curr. Opin. Mol. Ther. 2003 Dec;5(6):618-24
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Curr. Opin. Mol. Ther. 2003 Dec;5(6):618-242003-12-01 00:00:002019-02-15 09:22:25Overview of phase I studies of intravenous administration of PV701, an oncolytic virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-12-01 / Leuk. Lymphoma 2003 Dec;44(12):2031-82003-12-01 00:00:002019-02-15 08:51:25Dendritic cell-based immunotherapy in multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-11-03 / Br. J. Cancer 2003 Nov;89(9):1736-42
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-11-03 / Br. J. Cancer 2003 Nov;89(9):1736-422003-11-03 00:00:002019-02-15 08:36:25Clinical significance of immune cell infiltration within gallbladder cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-11-01 / Med. Pediatr. Oncol. 2003 Nov;41(5):478-80
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-11-01 / Med. Pediatr. Oncol. 2003 Nov;41(5):478-802003-11-01 00:00:002019-02-15 08:35:14Whole body thermochemotherapy in an infant with rhabdomyosarcoma and pulmonary metastases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-11-01 / Z Gastroenterol 2003 Nov;41(11):1101-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-11-01 / Z Gastroenterol 2003 Nov;41(11):1101-102003-11-01 00:00:002019-02-15 09:13:25Immunobiology and gene-based immunotherapy of hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-11-01 / Klin Padiatr 2003 Nov-Dec;215(6):303-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-11-01 / Klin Padiatr 2003 Nov-Dec;215(6):303-92003-11-01 00:00:002003-11-01 00:00:00An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2003-10-15 / J. Clin. Oncol. 2003 Oct;21(20):3826-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2003-10-15 / J. Clin. Oncol. 2003 Oct;21(20):3826-352003-10-15 00:00:002019-02-15 08:49:35Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8+ T-cell function in melanoma patients
